GeneID, a CLIA certified and CAP accredited molecular laboratory, provides the highest quality molecular testing services to medical practitioners. Our highly experienced pathologists and molecular geneticists are leaders in their field, with specialized knowledge and expertise. They provide informed and practical advice to assist with the interpretation of results. Our highly experienced pathologists are members of hospital boards and health policy committees and provide a renowned and comprehensive service to thousands of patients each year, reaching private and public hospital beds, specialists and general practitioners throughout the United States and worldwide.
Doctors face an ever-expanding variety of genetic tests that could influence how they care for their patients. Since the Human Genome Project was completed in 2003, the introduction of new genetic tests has far outpaced the capability of health practitioners. GeneID translates scientific discoveries into customized and more effective treatments for your patients. We can help to predict disease risk, or to determine how patients might respond to certain treatments. The same technologies that are improving the discovery of therapeutic molecules for cancer are being used by GeneID to enable providers to match drugs to patients based on their genetic profiles, to identify which health conditions an individual is susceptible to, and to determine how a given patient will respond to a particular therapy.
GeneID Lab has been offering its PGx solution to SNFs and ALs for almost two years. We are currently partnered with over 2,600 facilities and have performed over 170,000 tests.
As a leader company in Personalized Medicine, we assist you in the screening, diagnosis, and the optimization of drug therapy.
Doctors face an ever-expanding variety of genetic tests that could influence how they care for their patients. Since the Human Genome Project was completed in 2003, the introduction of new genetic tests has far outpaced the capability of health practitioners. GeneID translates scientific discoveries into customized and more effective treatments for your patients. We can help to predict disease risk, or to determine how patients might respond to certain treatments. The same technologies that are improving the discovery of therapeutic molecules for cancer are being used by GeneID to enable providers to match drugs to patients based on their genetic profiles, to identify which health conditions an individual is susceptible to, and to determine how a given patient will respond to a particular therapy.
GeneID Lab has been offering its PGx solution to SNFs and ALs for almost two years. We are currently partnered with over 2,600 facilities and have performed over 170,000 tests.
As a leader company in Personalized Medicine, we assist you in the screening, diagnosis, and the optimization of drug therapy.
